Guangdong Jiaying Pharmaceutical Co Ltd
002198
Company Profile
Business description
Guangdong Jiaying Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is mainly engaged in the research and development, production, and sales of pharmaceuticals. The company's main products cover throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal. Its product portfolio consists of Shuangliao Houfeng San, Chongganling Tablets, Jiegu Qili Tablets (Capsules), Shufeng Huoluo Tablets, Tiaojing Huoxue Tablets, etc.
Contact
Dongsheng Industrial Park
Zone B
Guangdong Province
Meizhou514021
CHNT: +86 7532321916
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
594
Stocks News & Analysis
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
stocks
Undervalued ASX share searches for cost savings
Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks
Chart of the Week: Where we see opportunities after year end market sell-off
The latest insights from our equity research team.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,983.30 | 28.90 | 0.32% |
| CAC 40 | 8,068.62 | 17.14 | -0.21% |
| DAX 40 | 24,186.49 | 108.12 | -0.45% |
| Dow JONES (US) | 48,458.05 | 245.96 | -0.51% |
| FTSE 100 | 9,649.03 | 54.13 | -0.56% |
| HKSE | 25,976.79 | 446.28 | 1.75% |
| NASDAQ | 23,195.17 | 398.69 | -1.69% |
| Nikkei 225 | 50,836.55 | 687.73 | 1.37% |
| NZX 50 Index | 13,406.91 | 11.04 | 0.08% |
| S&P 500 | 6,827.41 | 73.59 | -1.07% |
| S&P/ASX 200 | 8,697.30 | 32.40 | 0.37% |
| SSE Composite Index | 3,889.35 | 16.03 | 0.41% |